NCT02606682View on ClinicalTrials.gov

Phase 1 Study of NPT200-11 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

NPT200-11

Single doses of NPT200-11capsules, orally administered

DRUG

Placebo

Single doses of microcrystalline cellulose capsules, orally administered

Trial Locations (1)

85283

Celerion, Inc, Tempe

Sponsors
All Listed Sponsors
collaborator

UCB S.A. - Pharma Sector

INDUSTRY

lead

Neuropore Therapies Inc.

INDUSTRY

NCT02606682 - Phase 1 Study of NPT200-11 in Healthy Subjects | Biotech Hunter | Biotech Hunter